Drug intelligence / Profile preview

N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine

Development stage: Unknown
Modality: Peptides, Small Molecules

Overview

N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine is an experimental small molecule compound with the molecular formula C15H18I2N2O6 and a molecular weight of 576.12 g/mol[1][2]. It is a synthetic derivative of tyrosine containing two iodine atoms at positions 3 and 5 on the aromatic ring and is acetylated at the alpha-amino group. The compound also features D-threonine as part of its structure. There are no approved indications or clinical trials for this molecule as of now[1]. Its mechanism of action has not been described in available sources; however, structurally related iodinated tyrosines are known to be intermediates in thyroid hormone biosynthesis.

Other names: N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine

Beyond the preview

Go deeper on N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine.

Explore the full profile